Table 1.
Characteristics of study participants
| Characteristic | Fracture (n = 32) | No Fracture (n = 59) |
|---|---|---|
| eGFR (ml/min; median [range]) | 33 (7 to 68) | 30 (7 to 76) |
| Women (n [%]) | 19 (59) | 24 (41) |
| Age (years; mean ± SD) | 72 ± 9 | 70 ± 9 |
| Race (n [%]) | ||
| white | 15 (47) | 22 (37) |
| black | 4 (12) | 4 (7) |
| Hispanic | 13 (41) | 33 (56) |
| Weight (kg; mean ± SD) | 76 ± 17 | 81 ± 14 |
| Height (cm; mean ± SD) | 165 ± 10 | 165 ± 9 |
| BMI (mean ± SD) | 28 ± 5 | 29 ± 6 |
| Duration of kidney failure (years; median [range]) | 3.7 (0.2 to 26.0) | 5.1 (0.1 to 20.2) |
| Cause of kidney failure (n [%]) | ||
| diabetes or hypertension | 23 (72) | 42 (71) |
| nephritis/nephrosis | 2 (6) | 4 (7) |
| other | 7 (22) | 13 (22) |
| Laboratory parameters | ||
| serum calcium (mg/dl; mean ± SD) | 9.5 ± 0.6 | 9.4 ± 0.5 |
| serum phosphorus (mg/dl; mean ± SD) | 4.0 ± 1.0 | 3.8 ± 0.7 |
| serum bicarbonate (mM/L; mean ± SD) | 23.8 ± 3.6 | 23.0 ± 3.1 |
| Current alcohol consumption (n [%]) | 3 (9) | 7 (12) |
| Current smoking (n [%]) | 4 (12) | 9 (15) |
| Using a vitamin D supplement (n [%]) | 20 (74) | 36 (61) |
| Using a calcium supplement (n [%]) | 8 (27) | 12 (21) |
| Using phosphate binder (n [%]) | 5 (17) | 10 (17) |
P < 0.05. BMI, body mass index.